These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17222747)

  • 1. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency.
    Lichtman SM; Wildiers H; Launay-Vacher V; Steer C; Chatelut E; Aapro M
    Eur J Cancer; 2007 Jan; 43(1):14-34. PubMed ID: 17222747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
    Launay-Vacher V; Oudard S; Janus N; Gligorov J; Pourrat X; Rixe O; Morere JF; Beuzeboc P; Deray G;
    Cancer; 2007 Sep; 110(6):1376-84. PubMed ID: 17634949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.
    Body JJ; Coleman R; Clezardin P; Ripamonti C; Rizzoli R; Aapro M;
    Eur J Cancer; 2007 Mar; 43(5):852-8. PubMed ID: 17258449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
    Lichtman SM; Wildiers H; Chatelut E; Steer C; Budman D; Morrison VA; Tranchand B; Shapira I; Aapro M;
    J Clin Oncol; 2007 May; 25(14):1832-43. PubMed ID: 17488981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
    Tranchand B; Falandry C; You B; Girard P; Ribba B; Tod M; Freyer G
    Bull Cancer; 2008 May; 95 FMC Onco():F21-7. PubMed ID: 18511363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastering chemotherapy dose reduction in elderly cancer patients.
    Wildiers H
    Eur J Cancer; 2007 Oct; 43(15):2235-41. PubMed ID: 17686626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations.
    Launay-Vacher V; Chatelut E; Lichtman SM; Wildiers H; Steer C; Aapro M;
    Ann Oncol; 2007 Aug; 18(8):1314-21. PubMed ID: 17631561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL; Wagner JA
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency.
    Clark NP
    Thromb Res; 2008; 123 Suppl 1():S58-61. PubMed ID: 18809206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hematological malignancies in patients affected by renal failure.
    Niscola P; Vischini G; Tendas A; Scaramucci L; Giovannini M; Bondanini F; Romani C; Brunetti GA; Cartoni C; Cupelli L; Ferrannini M; Perrotti A; Del Poeta G; Palumbo R; de Fabritiis P
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):415-32. PubMed ID: 21417855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticancer drugs management in renal insufficiency patients].
    Zimmer-Rapuch S; Lheureux S; Brocard F; Janus N; Launay-Vacher V; Ray-Coquard I
    Bull Cancer; 2012 Mar; 99(3):323-31. PubMed ID: 22123599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose optimization of anticancer drugs in the elderly].
    Imamura CK
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):21-5. PubMed ID: 25596677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force.
    Audisio RA; Bozzetti F; Gennari R; Jaklitsch MT; Koperna T; Longo WE; Wiggers T; Zbar AP
    Eur J Cancer; 2004 May; 40(7):926-38. PubMed ID: 15093567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug management of prostate cancer: prevalence and consequences of renal insufficiency.
    Launay-Vacher V; Ayllon J; Janus N; Spano JP; Ray-Coquard I; Gligorov J; Pourrat X; Morere JF; Beuzeboc P; Deray G; Oudard S;
    Clin Genitourin Cancer; 2009 Oct; 7(3):E83-9. PubMed ID: 19815487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
    Spruill WJ; Wade WE; Cobb HH
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
    Nutescu EA; Spinler SA; Wittkowsky A; Dager WE
    Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interactions in medical oncology].
    Ishiguro H; Koshiji M; Morizane T; Taniai H; Enatsu S; Fujimoto T; Nambu Y
    Gan To Kagaku Ryoho; 2009 May; 36(5):879-85. PubMed ID: 19461200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function.
    Kintzel PE; Dorr RT
    Cancer Treat Rev; 1995 Jan; 21(1):33-64. PubMed ID: 7859226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.